American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

U.S. health officials are reviewing the $590M deal for bird flu shots that the Biden administration awarded to Moderna (MRNA) in January, ...

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.

Last year, the administration of former President Joe Biden allocated more than $800 million to combat bird flu in livestock.

The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr comes as the U.S. records its first ...